Hao Lin, Xinli Zhou, Xiaofang Sheng, & Xiaohua Liang. (2023). Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationHao Lin, Xinli Zhou, Xiaofang Sheng, and Xiaohua Liang. Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma. Adis, Springer Healthcare, 2023.
MLA (9th ed.) CitationHao Lin, et al. Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma. Adis, Springer Healthcare, 2023.
Warning: These citations may not always be 100% accurate.